Contact:

Mentor/Principal InvestigatorRobert P. Kimberly, M.D. Professor  Mailing address: SHEL 176, 1530 3RD AVENUE S, BIRMINGHAM AL 35294-2182  Telephone: (205) 934-0245  E-mail: rpk@uab.edu


Postdoctoral Position Available:  Autoimmunity and Immunologic Mechanisms

Research opportunities are available in cellular and molecular immunology; genetic organization and variation of immune response genes; structure and function of immunoglobulins; transgenic models of immune function; host responses to infectious agents; transplantation immunology; and neuroimmunology.

The primary emphasis of the program is the unraveling of pathogenetic mechanisms operative in diseases of immune etiology. Mentors involved in both their own research programs and in the care of patients with autoimmune and immune-mediate inflammatory diseases provide an opportunity for translational work between basic and applied immunology. Opportunities in human biology and disease are available in autoimmune and immune-mediated inflammatory diseases, immunodeficiencies, malignant diseases, host-defense defense including vaccine development, and transplantation immunology. Outstanding investigator-based and core-based facilities are available. Resources include state-of-the-art high-speed flow cytometry, high resolution imaging (confocal, FRET, standard and cryo-electron microscopy), nucleic acid and protein sequencing, hybridoma/phage display antibody production, and transgenic/ES cell mouse facilities.

Postdoctoral trainees with an M.D., Ph.D., or equivalent terminal degree are selected on the basis of prior academic and research performance, letters of recommendation, and personal interviews. Successful candidates will demonstrate strong commitment to a research and teaching career in academic immunology. For further information, please contact Dr. Robert Kimberly, E-mail: rpk@uab.edu.

Postdocs in UAB News

More Items

UAB Research News

  • Blocking specific neuron interaction may slow Parkinson's progression
    Two experimental drugs that block LRRK2 kinase enzyme were shown to lessen aggregations of alpha synuclein protein, which have been shown to play a role in the development of Parkinson's disease, report researchers at the University of Alabama Birmingham.
  • UAB optometrist improves treatment and care for patients with dry eye
    Kelly Nichols, O.D., Ph.D., a dry eye expert and dean of the University of Alabama at Birmingham School of Optometry, conducted research studies for the parent drug company to explore the efficacy and safety of lifitegrast in treating this eye condition that affects more than 16 million adults in the United States.
More Items